Anne Trinh

ID Genomics (United States) — United States

Medicine · Health Sciences

21h-index2.7kcitations150works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(24), Cytokine Signaling Pathways and Interactions(23), Genetic factors in colorectal cancer(22), Cancer Immunotherapy and Biomarkers(21), Immunotherapy and Immune Responses(18)

Publications150 total

GLIMPSE: A Lightweight SHAP-Based Framework for Interpretable ALS Biomarker Discovery from Gene Expression Data
Lecture notes in computer science·2026
Supplementary Table S9 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Figures from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S7 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S6 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S4 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Amyotrophic lateral sclerosis diagnosis using machine learning and multi-omic data integration
Heliyon·2024· 9 citedOpen Access
Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors
Experimental Hematology·2024· 3 citedOpen Access
Heterogeneity and transcriptional drivers of triple-negative breast cancer
Cell Reports·2023· 25 citedOpen Access
Supplementary Figure from Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
2023Open Access
Supplementary Table from Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
2023Open Access
Data from Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
2023Open Access
Supplementary Table from Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
2023Open Access
Supplementary Figure from Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
2023Open Access
Supplementary Table from Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Kornélia Polyák(22), Louis Vermeulen(11), Bojana Jovanović(11), Nicholas W. Harper(11), Florian Markowetz(10), Franziska Michor(10), Shaokun Shu(10), So Yeon Park(9), Maša Alečković(9), Vanessa Almendro(8), Laura E. Stevens(8), Guillermo Peluffo(8), Natalie L. Kingston(8), Jan Paul Medema(7), Kari Trumpi(7), Onno Kranenburg(7), Cornelis J.A. Punt(7), Xintao Qiu(7), Anne Fassl(7), Piotr Siciński(7)